Core Viewpoint - Spring Medical (01858.HK) has entered into agreements with Beijing Bank for structured deposit products, utilizing temporary idle funds raised from its A-share public offering, totaling RMB 2.9 billion and RMB 2.1 billion for different branches [1] Company Summary - Spring Medical has agreed to invest a total of RMB 2.9 billion in structured deposits with Beijing Bank (Daxing Branch) and RMB 2.1 billion with Beijing Bank (Fangzhuang Branch) [1] - Additionally, the company will use internal resources to invest another RMB 2.9 billion in structured deposits with Beijing Bank (Fangzhuang Branch) [1] - As of November 11, 2025, Spring Medical's stock closed at HKD 19.12, with a slight increase of 0.21% and a trading volume of 860,000 shares, amounting to HKD 16.44 million [1] Industry Summary - Spring Medical's market capitalization is HKD 1.815 billion, ranking 17th in the medical device II industry [1] - Key performance indicators for Spring Medical compared to the industry average are as follows: - ROE: 5.6% vs. -4.03% (ranked 10th) - Market capitalization: HKD 1.815 billion vs. HKD 5.268 billion (ranked 17th) - Revenue: HKD 913 million vs. HKD 1.195 billion (ranked 10th) - Net profit margin: 23.48% vs. -16.5% (ranked 5th) - Gross margin: 67.09% vs. 54.89% (ranked 11th) - Risk rate: 16.62% vs. 29.03% (ranked 65th) [1]